Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA
- PMID: 17239465
- DOI: 10.1016/j.virusres.2006.12.011
Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA
Abstract
We recently established a genome-length HCV RNA-replicating cell line (O strain of genotype 1b; here called O cells) using cured cells derived from sO cells, in which HCV subgenomic replicon RNA with an adaptive NS5A mutation (S2200R) is replicated. Characterization of the O cells revealed a second adaptive NS3 mutation (K1609E) required for genome-length HCV RNA replication. To clarify the role of adaptive mutation in genome-length HCV RNA replication, we newly established one and three kinds of genome-length HCV RNA-replicating cell lines possessing the cell background of sO and O cells, respectively, and found additional adaptive NS3 mutations (Q1112R, P1115L, and E1202G) required for the robust replication of genome-length HCV RNA. We further found that specific combinations of adaptive NS3 mutations drastically enhanced HCV RNA replication, regardless of the cell lines examined. These findings suggest that specific viral factors may affect the replication level of genome-length HCV RNA.
Similar articles
-
[Replication of hepatitis C virus genome].Uirusu. 2008 Dec;58(2):191-8. Uirusu. 2008. PMID: 19374197 Review. Japanese.
-
New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.Biochem Biophys Res Commun. 2008 Jun 20;371(1):104-9. doi: 10.1016/j.bbrc.2008.04.005. Epub 2008 Apr 10. Biochem Biophys Res Commun. 2008. PMID: 18406345
-
Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.J Virol. 2005 Mar;79(5):2788-96. doi: 10.1128/JVI.79.5.2788-2796.2005. J Virol. 2005. PMID: 15708997 Free PMC article.
-
Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.Biochem Biophys Res Commun. 2005 Apr 22;329(4):1350-9. doi: 10.1016/j.bbrc.2005.02.138. Biochem Biophys Res Commun. 2005. PMID: 15766575
-
In vitro replication models for the hepatitis C virus.J Viral Hepat. 2007 Jan;14(1):2-10. doi: 10.1111/j.1365-2893.2006.00807.x. J Viral Hepat. 2007. PMID: 17212638 Review.
Cited by
-
New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication.PLoS One. 2013 Aug 30;8(8):e72519. doi: 10.1371/journal.pone.0072519. eCollection 2013. PLoS One. 2013. PMID: 24023620 Free PMC article.
-
Modulation of host metabolism as a target of new antivirals.Adv Drug Deliv Rev. 2007 Oct 10;59(12):1277-89. doi: 10.1016/j.addr.2007.03.021. Epub 2007 Aug 11. Adv Drug Deliv Rev. 2007. PMID: 17897752 Free PMC article. Review.
-
Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities.FASEB Bioadv. 2021 Mar 4;3(5):356-373. doi: 10.1096/fba.2020-00107. eCollection 2021 May. FASEB Bioadv. 2021. PMID: 33977235 Free PMC article.
-
Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture.Int J Biomed Sci. 2008 Jun;4(2):82-8. Int J Biomed Sci. 2008. PMID: 23675072 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources